title: Membrane lipid-modulated mechanism of action and non-cytotoxicity of novel fungicide aminoglycoside FG08.
abstract: A novel aminoglycoside, FG08, that differs from kanamycin B only by a C8 alkyl chain at the 4″-O position, was previously reported. Unlike kanamycin B, FG08 shows broad-spectrum fungicidal but not anti-bacterial activities. To understand its specificity for fungi, the mechanism of action of FG08 was studied using intact cells of the yeast Saccharomyces cerevisiae and small unilamellar membrane vesicles. With exposure to FG08 (30 µg mL(-1)), 8-fold more cells were stained with fluorescein isothiocyanate, cells had 4 to 6-fold higher K(+) efflux rates, and 18-fold more cells were stained with SYTOX Green in comparison to exposure to kanamycin B (30 µg mL(-1)). Yeast mutants with aberrant membrane sphingolipids (no sphingoid base C4 hydroxyl group, truncated very long fatty acid chain, or lacking the terminal phosphorylinositol group of mannosyl-diinositolphosphorylphytoceramide were 4 to 8-fold less susceptible to growth inhibition with FG08 and showed 2 to 10-fold lower SYTOX Green dye uptake rates than did the isogenic wild-type strain. FG08 caused leakage of pre-loaded calcein from 50% of small unilamellar vesicles with glycerophospholipid and sterol compositions that mimic the compositions of fungal plasma membranes. Less than 5 and 10% of vesicles with glycerophospholipid and sterol compositions that mimic bacterial and mammalian cell plasma membranes, respectively, showed calcein leakage. In tetrazolium dye cytotoxicity tests, mammalian cell lines NIH3T3 and C8161.9 showed FG08 toxicity at concentrations that were 10 to 20-fold higher than fungicidal minimal inhibitory concentrations. It is concluded that FG08's growth inhibitory specificity for fungi lie in plasma membrane permeability changes involving mechanisms that are modulated by membrane lipid composition.
authors.affiliation: Department of Biology, Utah State University, Logan, Utah, United States of America ; Synthetic Bioproducts Center (USTAR), Utah State University, North Logan, Utah, United States of America.
authors.forename: Sanjib
authors.initials: S
authors.lastname: Shrestha
authors.forename: Michelle
authors.initials: M
authors.lastname: Grilley
authors.forename: Marina Y
authors.initials: MY
authors.lastname: Fosso
authors.forename: Cheng-Wei T
authors.initials: CW
authors.lastname: Chang
authors.forename: Jon Y
authors.initials: JY
authors.lastname: Takemoto
mesh_terms: D000617:Aminoglycosides / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D018699:Coated Vesicles / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005452:Fluoresceins / Q000378:metabolism; D005456:Fluorescent Dyes / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism*; D051379:Mice; D008826:Microbial Sensitivity Tests; D009154:Mutation; D041681:NIH 3T3 Cells; D011188:Potassium / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D013107:Sphingolipids / Q000096:biosynthesis; D014312:Trisaccharides / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity
chemical_list: D000617:Aminoglycosides; D000935:Antifungal Agents; C554556:FG08 compound; D005452:Fluoresceins; D005456:Fluorescent Dyes; D008563:Membrane Lipids; D013107:Sphingolipids; D014312:Trisaccharides; D011188:Potassium; C007740:fluorexon
references.citation: J Biol Chem. 2001 Sep 21;276(38):35714-22
references.pmid: 11473117
references.citation: Clin Microbiol Rev. 2003 Jul;16(3):430-50
references.pmid: 12857776
references.citation: J Biol Chem. 2008 May 23;283(21):14445-52
references.pmid: 18339623
references.citation: Antimicrob Agents Chemother. 2000 May;44(5):1174-80
references.pmid: 10770748
references.citation: J Antibiot (Tokyo). 1957 Sep;10(5):181-8
references.pmid: 13513509
references.citation: FEMS Microbiol Lett. 2003 Sep 12;226(1):169-73
references.pmid: 13129623
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15997-6002
references.pmid: 17038500
references.citation: J Appl Microbiol. 2005;99(4):836-43
references.pmid: 16162234
references.citation: J Mol Biol. 2001 Mar 9;306(5):1037-58
references.pmid: 11237617
references.citation: Adv Exp Med Biol. 2010;688:217-31
references.pmid: 20919657
references.citation: J Antibiot (Tokyo). 2010 Nov;63(11):667-72
references.pmid: 20924381
references.citation: Biochemistry. 1978 Apr 4;17(7):1143-9
references.pmid: 656378
references.citation: Br J Clin Pharmacol. 1995 Jun;39(6):597-603
references.pmid: 7654476
references.citation: J Natl Cancer Inst. 2007 Feb 21;99(4):309-21
references.pmid: 17312308
references.citation: Biochemistry. 2009 Jan 20;48(2):313-27
references.pmid: 19113844
references.citation: Biochem J. 2004 Jun 15;380(Pt 3):859-65
references.pmid: 15032749
references.citation: J Biol Chem. 1998 May 1;273(18):11062-8
references.pmid: 9556590